Common analysis pitfalls in longitudinal ctDNA studies: lead time, sensitivity and immortal time bias
{{output}}
Circulating tumour DNA (ctDNA) has emerged as one of the most promising biomarkers in oncology, with potential applications from detection of minimal residual disease (MRD) and diagnosis to prognosis, treatment guidance, and response monitoring. This personal ... ...
